Patent · US Active

Therapeutic formulations of desoxyepothilones

US8618085B2 · kind B2 · utility

1Cited by

7References

15Claims

0Family size

Assignee

Koasn Biosciences Incorporated · US

Inventors

Peter Licari · Fremont, US
Ziyang Zhong · Belmont, US
Indu Isaacs · Andover, US
John G. Augustine · Lynn, US

Key dates

Filing date	Mar 15, 2005
Grant date	Dec 31, 2013
Priority date	—
Expiry date	Mar 27, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Formulations of desoxyepothilones are stable before and after dilution into aqueous media.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.